ResearchRSS2 days ago
Scientists at Texas A&M University found a protective pathway in the brain that could slow Parkinson's disease progression. This pathway involves receptors that respond to nicotine (a chemical in tobacco) but doesn't require actually using tobacco. In mice, increasing these receptors helped prevent Parkinson's symptoms — but only in female mice, not male mice.
WHY IT MATTERSThis sex-specific finding could lead to new Parkinson's treatments tailored differently for women and men, addressing a gap in how the disease progresses differently between sexes.
ResearchBIORXIVMay 16
Scientists studied DNA samples and brain cells from 190 people—115 without Parkinson's disease and 75 with it—to understand how genetic differences affect how brain cells work. They used advanced technology to read entire genomes and map which genes are active in different brain cell types. This research helps explain how over 100 genetic risk factors discovered in previous studies actually increase someone's chance of developing Parkinson's disease.
WHY IT MATTERSThis research could eventually help doctors predict who is at highest genetic risk for Parkinson's disease and identify new drug targets by showing exactly how disease-linked genetic variations disrupt brain cell function.
ResearchRSSMay 14
Vyalev is a new under-the-skin pump that delivers Parkinson's disease medication continuously. In a real-world study, it reduced the amount of time patients experienced symptoms and improved both movement problems and some other symptoms like mood or sleep issues. Patients also reported better quality of life.
WHY IT MATTERSIf you have advanced Parkinson's disease and struggle with medication wearing off between doses, Vyalev offers a continuous delivery option that may reduce symptom fluctuations and improve daily functioning.
ResearchBIORXIVMay 13
Researchers studied two proteins called GPNMB and glycosphingolipids in blood and spinal fluid samples from Parkinson's disease patients. These proteins may be important markers that show when the brain's waste-disposal system (called lysosomes) isn't working properly in Parkinson's disease. This early-stage research could help doctors better understand and diagnose Parkinson's disease in the future.
WHY IT MATTERSIf GPNMB and glycosphingolipid measurements prove reliable, they could become blood tests that help diagnose Parkinson's disease earlier, before major symptoms appear, potentially allowing earlier treatment.
ResearchRSSMay 12
A large study from South Korea found that people with chronic allergies like asthma and hay fever may have a higher risk of developing Parkinson's disease. Researchers think this happens because allergies cause long-term inflammation in the body, which keeps certain immune cells at high levels. Scientists still need to do more research to understand exactly how allergies and Parkinson's are connected.
WHY IT MATTERSIf you have chronic allergies or asthma, this research suggests managing your allergic inflammation carefully might be one way to potentially reduce your Parkinson's disease risk, though more research is needed to confirm this link.
ResearchBIORXIVMay 9
Researchers studied how Parkinson's disease affects men and women differently by examining genetic and protein data from thousands of patients. They found that certain genes and biological pathways that cause Parkinson's work differently in males versus females, which could explain why men and women experience this disease differently. This discovery could lead to treatments designed specifically for each sex.
WHY IT MATTERSUnderstanding sex-specific causes of Parkinson's disease could enable doctors to develop targeted treatments that work better for men or women individually, rather than using one-size-fits-all approaches.
ResearchRSSMay 8
The Michael J. Fox Foundation renamed its large Parkinson's disease study from the Parkinson's Progression Markers Initiative to the Parkinson's Precision Medicine Initiative. This name change shows how the study has evolved to focus on personalized medicine approaches. The study tracks Parkinson's patients over time to better understand the disease and find treatments tailored to individual patients.
WHY IT MATTERSIf you have Parkinson's disease, this study's shift toward precision medicine means researchers are working to identify which treatments will work best for your specific type of Parkinson's based on your individual characteristics.
ResearchRSSMay 7
Researchers found that a special type of food supplement called a prebiotic can help restore healthy bacteria in the guts of people with Parkinson's disease. Even better, they discovered a simple blood test that can measure tiny particles to show whether the treatment is working. This blood test tracks signals that travel between the gut and the brain.
WHY IT MATTERSFor Parkinson's patients, this offers a non-invasive way to monitor whether gut-targeted treatments are actually working, potentially opening a new avenue for managing symptoms through gut health.
ResearchBIORXIVMay 7
Scientists discovered that a protein called WDR44 helps trigger the clumping of another protein called alpha-synuclein inside brain cells, specifically at structures called lysosomes (which are like the cell's trash cans). This clumping is what causes Parkinson's disease. By watching this process happen in real-time in living neurons, researchers got a clearer picture of how the disease starts.
WHY IT MATTERSUnderstanding exactly where and how alpha-synuclein clumping begins could lead to new Parkinson's treatments that stop the process at its earliest stage, potentially slowing or preventing neuronal damage before symptoms appear.
ResearchRSSMay 6
A woman with early-onset Parkinson's disease caused by a VPS13C gene mutation initially improved with medication and deep brain stimulation surgery, but then got much worse over time. Her motor symptoms (movement problems) and nonmotor symptoms (like mood or sleep issues) worsened rapidly, eventually making it impossible for her to live on her own. This case suggests that genetic causes of Parkinson's disease may affect how well standard treatments work.
WHY IT MATTERSIf you have VPS13C-related Parkinson's disease, this case shows that standard treatments like deep brain stimulation may not work as well long-term, so you should discuss genetic testing and personalized treatment plans with your neurologist.
ResearchRSSMay 5
Scientists used fruit flies to study Parkinson's disease and found three genes that might be important for treating it. When researchers changed these genes in fruit flies, the flies moved better. This discovery could help doctors develop new treatments for Parkinson's disease in the future.
WHY IT MATTERSIf these genes prove to be valid targets in human clinical trials, they could lead to new Parkinson's treatments that address movement problems through a different biological pathway than current medications.
ResearchRSSMay 1
Researchers tested whether a probiotic supplement could help reduce anxiety in people with Parkinson's disease. The supplement did not work better than a placebo (a fake pill) for anxiety. However, people who took the supplement did show some improvement in thinking and memory tests, though researchers said this result needs more study before drawing conclusions.
WHY IT MATTERSIf probiotics could help with cognitive symptoms in Parkinson's disease, it might offer a simple, accessible option alongside standard treatments—but this trial suggests anxiety relief isn't one of those benefits.
ResearchRSSApr 29
Researchers found that simple gut biopsies might detect signs of Parkinson's disease years before a person develops movement problems or other symptoms. They discovered that more than half of people with digestive issues but no diagnosed neurological disease showed protein misfolding in their gut tissue. This could allow doctors to identify people at high risk for Parkinson's much earlier than currently possible.
WHY IT MATTERSIf validated, routine gut biopsies could identify Parkinson's disease risk years before symptoms appear, potentially allowing earlier intervention when treatments might be most effective.
ResearchRSSApr 28
Scientists discovered that in Parkinson's disease, clumps of a toxic protein called alpha-synuclein damage not just brain cells but also the tiny blood vessels that supply the brain. These two types of damage likely work together to make the disease worse over time. This finding helps explain why Parkinson's affects the brain in multiple ways.
WHY IT MATTERSUnderstanding that blood vessel damage contributes to Parkinson's progression could lead to new treatments that protect blood vessels, potentially slowing disease advancement beyond current approaches that only target brain cell damage.
ResearchRSSApr 27
A new study found that women with Parkinson's disease are much less likely than men to choose a brain surgery called deep brain stimulation (DBS). The main reason is that women often worry about being a burden on their family and don't have as much support available to help them through the procedure and recovery.
WHY IT MATTERSIf you're a woman with Parkinson's considering DBS, understanding that support concerns are common may help you have more honest conversations with your doctor and family about what you actually need to move forward with treatment.